share_log

Petros Pharmaceuticals Q4 EPS $(2.17) Misses $(1.11) Estimate, Sales $364.25K Miss $1.55M Estimate

Benzinga ·  Apr 2 08:12

Petros Pharmaceuticals (NASDAQ:PTPI) reported quarterly losses of $(2.17) per share which missed the analyst consensus estimate of $(1.11) by 95.5 percent. This is a 6.9 percent decrease over losses of $(2.03) per share from the same period last year. The company reported quarterly sales of $364.25 thousand which missed the analyst consensus estimate of $1.55 million by 76.50 percent. This is a 54.36 percent decrease over sales of $798.10 thousand the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment